Strong Financial Performance in Q1

GE HealthCare Technologies Inc. announced a notable 3% year-on-year revenue increase to $4.8 billion in the first quarter of fiscal 2025, exceeding market expectations. This performance underscores the company's robust growth trajectory and operational efficiency.

Significant Net Income and EPS Growth

The company reported a dramatic 50.8% surge in net income to $564 million, compared to the same quarter in 2024. Diluted earnings per share (EPS) also saw an impressive 51.85% annual increase, reaching $1.23. In a move to return value to shareholders, GE HealthCare unveiled a $1 billion share repurchase program.

Strategic Acquisitions and Future Outlook

CEO Peter Arduini highlighted the company's strong execution and growth strategies, including the recent acquisition of Nihon Medi-Physics. This acquisition is expected to enhance global access to next-generation radiopharmaceuticals, further solidifying GE HealthCare's market position.

Following the announcement, GE HealthCare's stock price experienced a 2.81% increase in premarket trading, reaching $70 per share at 6:29 am ET.